Bacterial Infectious Diseases Research Articles

Tackling Pertussis in Schools: A Public Health Unit’s Approach

Abstract Issue Pertussis is a highly infectious bacterial respiratory disease, easily transmitted in closed settings, such as schools. In Portugal, 2019 was the last year with a significant number of cases (83). As pertussis usually follows epidemic cycles from 3 to 5 years, another wave is expected in 2024. Children aged 1-5 years are particularly vulnerable as they no longer benefit from maternal vaccination and have not yet received the 5-year boost recommended in the national schedule. Description of the problem In April 2024, the Cascais Public Health Unit (PHU) addressed two possible pertussis cases in preschools. A streamlined response protocol was drafted, including an online contact tracing form and task distribution among response team members, along with templates and a scripted guide for standardized communication. Results We were provided a list of close contacts for the children and staff and shared an online form. In the first case, 34 in 35 identified contacts responded to the form, while in the second case, 38 in 55. When comparing both scenarios, the average scripted call duration decreased from 10 to 6 minutes. The PHU response to the first index case took 6 hours, involving 4 physicians and 5 nurses, whereas to the second took 4 hours, involving 3 physicians and 3 nurses. However, implementation requires at least one team member with basic information technology skills to set up the system. Lessons Clear communication channels between schools and public health authorities are vital for effective outbreak management. Streamlining communication processes with online forms and scripted conversation guides improved efficiency. Centralised data collection reduced response time and resource requirements in each outbreak. Key messages • Established communication channel, standardized data collection, and streamlined protocol allow more effective outbreak management. • Centralized data collection via digital tools is particularly useful in limited human resources settings.

Therapeutic effects and mechanisms of Modified Ma-Xing-Shi-Gan Decoction on Klebsiella pneumoniae-induced pneumonia in mice assessed by Multi-omics

Ethnopharmacological relevanceModified Ma-Xing-Shi-Gan decoction (MMXSGD), a classic prescription from Treatise on Febrile Disease in China, is commonly used to treat Klebsiella pneumoniae (KP) infections in clinical settings. Materials and methodsThe aim of this study is to assess the efficacy of MMXSGD in the treatment of pneumonia and investigate its underlying mechanism of action. UHPLC-MS/MS was established to identify the main chemical components of serum after intragastric administration with MMXSGD. A mouse model of pneumonia caused by KP was used to evaluate the therapeutic potential of MMXSGD. The macrophage polarization was analyzed by immunohistochemistry. The cytokine profile was assessed using Luminex assay. Lung transcript and metabolite levels were assessed by transcriptomics and non-targeted metabolomics to analyze potential anti-pneumonia mechanisms and targets. Results22 major blood-entry components and 274 MMXSGD-pneumonia-related targets were identified. Compared with the model group, the mortality rate of mice in different dosage groups of MMXSGD was significantly reduced, and pathological lung damage was significantly alleviated. Among them, the low dose of MMXSGD treatment had the best protective effect. Further, MMXSGD treatment could regulates M1/M2 polarization in macrophages and inhibits the production of pro-inflammatory cytokines. The data from transcriptome and metabolome analysis indicate that MMXSGD could regulate inflammation-related pathways (PI3K/AKT, HIF-1, NF-κB pathway) and metabolites to modulate pulmonary inflammation. The results demonstrate that MMXSGD enhances the antibacterial effect in vivo by suppressing inflammation and regulating immunity rather than directly antibacterial effect. ConclusionThese findings provide a further assessment of MMXSGD, suggesting that MMXSGD has good therapeutic efficacy in bacterial infectious diseases.

Lactoferrin: a secret weapon in the war against pathogenic bacteria

The excessive use of antibiotics to treat bacterial infectious diseases in all living beings has caused a global epidemic of bacterial resistance to antibiotics, leading to the emergence of multidrug-resistant and pandrug-resistant strains. In 2019, the World Health Organization (WHO) reported that antimicrobial resistance causes at least 700,000 deaths per year worldwide. Therefore, in this global war against microorganisms, a therapeutic alternative is necessary to help us win this battle. A key in this race against the clock could be lactoferrin (Lf), a cationic glycoprotein of the mammalian innate immune system that is highly conserved among mammals. Lf is a multifunctional glycoprotein with immunomodulatory, anticarcinogenic, wound-healing, antioxidant, antimicrobial, and bone regeneration properties, in addition to improving the gut microbiota. Lf limits the growth of microorganisms through the sequestration of iron but can also interact directly with some components of the outer membrane of Gram-negative bacteria or bind to teichoic acids in Gram-positive bacteria, destabilizing the membrane and resulting in lysis. Moreover, cleavage of the Lf molecule could promote the production of lactoferricins (Lfcins) and lactoferrampin (Lfampin) from the N-terminal end, which are known to often have stronger antimicrobial effects than the native molecule, as well as analogous peptides, such as HLopt2, which have also shown enhanced antimicrobial activity. Bovine Lf (bLf) has been approved by the US Food and Drug Administration (FDA), and the European Food Safety Authority for its use as a dietary supplement in food products. Because of its effectiveness, accessibility, low cost, and nontoxicity, Lf could be a promising alternative for preventing or treating infections in animals and humans.

Combining Mesoporous Bioactive Glass Nanoparticles (MBGNs) with Essential Oils to Tackle Bacterial Infection and Oxidative Stress for Bone Regeneration Applications.

Bacterial infectious diseases remain one of the significant challenges in the field of bone regeneration applications. Despite the development of new antibiotics, their improper administration has led to the development of multiresistant bacterial strains. In this study, we proposed a novel approach to tackle this problem by loading clove oil (CLV), a natural antibacterial compound, into amino-functionalized mesoporous bioactive glass nanoparticles (MBGNs). The scanning electron microscopy images (SEM) revealed that amino-functionalization and CLV loading did not affect the shape and size of the MBGNs. The successful grafting of the amino groups on the MBGNs' surface and the presence of CLV in the material were confirmed by attenuated total reflectance-Fourier transform infrared (ATR-FTIR) spectroscopy and zeta potential measurements. The increased CLV concentration led to a higher loading capacity, encapsulation efficiency, and antioxidant activity. The in vitro CLV release profile exhibited an initial burst release, followed by a controlled release over 14 days. The loading of CLV into MBGNs led to a stronger antibacterial effect against E. coli and S. aureus, while MG-63 osteoblast-like cell viability was enhanced with no morphological changes compared to the control group. In conclusion, the CLV-MBGNs nanocarriers showed promising properties in vitro as novel drug delivery systems, exploiting essential oils for treating bone infections and oxidative stress.

Dual-modal detection of antimicrobial susceptibility in pathogenic bacteria based on the high-throughput microfluidic platform

For pathogenic bacterial infectious diseases such as sepsis, accurate and rapid antimicrobial susceptibility testing (AST) plays an important role in improving antimicrobial screening and clinical outcomes. Traditional culture-based AST assays have the limitations of time-consuming, labor-intensive, expensive, and consuming reagents. In this work, a simple, fast, high-throughput microfluidic platform integrated with isolation, identification, and detection functions was designed for antibiotic susceptibility analysis in pathogenic bacteria. For the above purpose, MnO2@ZIF-90 nanoprobes with dual functions of nanozyme and fluorescence were prepared for visual eye or RGB analysis through a smartphone APP. More importantly, the redox activity of bacterial membrane in active pathogenic bacteria could decompose the MnO2 of MnO2@ZIF-90 nanoprobes and reduce the enzyme-like activity, which weakens the colorimetric signal of Timebox. Meanwhile, the ATP released from active pathogenic bacteria further triggered the breakdown of the inner ZIF-90 layer, generating a fluorescence signal. Therefore, a dual detection combining colorimetric and fluorescence was used to perform more accurate and reliable antibiotic susceptibility analysis of pathogenic bacteria. With the proposed microfluidic platform, a low detection of 10 CFU mL−1 bacteria and fast AST results were achieved within 5 min. The clinical applicability of the platform was further demonstrated through the analysis of clinical samples. This work provides a low-cost, easy-to-operation, fast-response, and high-throughput platform for the AST assays in pathogenic bacterial infectious diseases such as sepsis.

Occurrence and seroprevalence of infectious viral, bacterial, and protozoal diseases among patients attending the Ore General Hospital in southwestern Nigeria

Infectious diseases caused by viruses, bacteria, protozoans, and fungi continue to pose significant challenges globally, with transmission routes including person-to-person contact, animal vectors, and environmental exposure. Despite global efforts to control these diseases, limited studies and resource constraints in Ore, Nigeria, have led to increasing prevalence, highlighting the need for targeted public health interventions. This study aimed to determine the distribution of infectious diseases among patients attending General Hospital Ore, Odigbo, Nigeria. Serum samples from consenting patients were assayed for the presence of malaria parasites, human immunodeficiency virus (HIV), hepatitis B surface antigen (HBsAg), Salmonella infection, Helicobacter pylori infection, high vaginal swab (HVS) results, and urinary tract infections (UTIs). The subjects included 1900 males (38.8%) and 3000 females (61.2%). The overall prevalence rates were as follows: HIV (40%), malaria (35%), typhoid (37.5%), HBsAg (20%), H. pylori (6.3%), HVS (45%), and UTIs (10%). The high rates of infectious diseases observed in this study, compared to rates reported elsewhere, suggest the need to strengthen public health measures and infection prevention strategies in the area. In addition, routine screening for these diseases and early passive or active immunization for vaccine-preventable diseases are essential to further reduce the burden of these infections.

Safety, pharmacokinetics, and food-effect of pivmecillinam after single- and multiple-dose in healthy Chinese subjects: a phase I study.

Urinary tract infection (UTI) is one of the most prevalent bacterial infectious diseases worldwide. However, the resistance of urinary pathogens to other UTI antibiotics such as trimethoprim and trimethoprim/sulphamethoxazole increased. Pivmecillinam is a prodrug of mecillinam, which is effective for the treatment of urinary tract infections. The purpose of this study was to assess the safety, and pharmacokinetics of pivmecillinam and mecillinam after single- and multiple-dose oral administration of pivmecillinam tablets in healthy Chinese subjects. The study also investigated the profile of urinary excretion of mecillinam, as well as the effect of food and gender on the pharmacokinetics of pivmecillinam and mecillinam. This study was a single-center, open-label phase I study carried out in three groups. In total, 34 subjects were included in the study: group 1-food effect study with pivmecillinam 200mg (n = 12); group 2-single- and multiple-dose study with pivmecillinam 400mg (n = 12); group 3-single dose study with pivmecillinam 600mg (n = 10). The plasma and urine concentrations of pivmecillinam and mecillinam were measured, and their pharmacokinetics were calculated. Treatment-emergent adverse events were evaluated and recorded in safety assessments for three groups. No severe adverse events were found in this study. After a single dose of pivmecillinam was taken orally, the maximum plasma concentration (Cmax) and the area under the concentration-time curve (AUC) of pivmecillinam increased in a dose-proportional manner, nor did mecillinam. Food had significant effects on Cmax and AUC0-t of pivmecillinam and Cmax of mecillinam. The mean cumulative percentage of urine excretion of mecillinam at 0 to 24h ranged from 35.5 to 44.0%. Urinary cumulative excretion is relative to the drug dose, but the diet and multiple-dose administration did not affect the urinary cumulative excretion rate. The safety and pharmacokinetics of pivmecillinam and mecillinam after single- (200/400/600mg) or multiple-dose (400mg) administration were demonstrated in healthy Chinese subjects. Food affected the pharmacokinetics of pivmecillinam and mecillinam.

A REFLECTION ON PUBLIC POLICIES IN COMBATING TUBERCULOSIS. A WORLDWIDE PANORAMA

A reflection on public policies to combat Tuberculosis. A global panorama Tuberculosis is an infectious bacterial disease caused by Mycobacterium tuberculosis, mainly affecting the lungs and transmitted from person to person through respiratory droplets. Although the infection does not always cause symptoms in healthy people, when active, it can cause coughing, chest pain, weakness, weight loss and fever. Tuberculosis is currently a global health concern, with millions of deaths and new infections each year, due to factors such as drug resistance, HIV, international travel and homelessness. With a third of the world’s population infected, it is essential that healthcare professionals understand the disease and its diagnostic procedures. New research should focus on the social factors that determine TB. In this way, it is believed, Brazil will once again be able to celebrate reaching the WHO targets for the elimination of TB by 2035.

Bacterial Membrane Vesicles: The Missing Link Between Bacterial Infection and Alzheimer Disease.

Periodontitis is a common chronic inflammatory disease, affecting approximately 19% of the global adult population. A relationship between periodontal disease and Alzheimer disease has long been recognized, and recent evidence has been uncovered to link these 2 diseases mechanistically. Periodontitis is caused by dysbiosis in the subgingival plaque microbiome, with a pronounced shift in the oral microbiota from one consisting primarily of Gram-positive aerobic bacteria to one predominated by Gram-negative anaerobes, such as Porphyromonas gingivalis. A common phenomenon shared by all bacteria is the release of membrane vesicles to facilitate biomolecule delivery across long distances. In particular, the vesicles released by P gingivalis and other oral pathogens have been found to transport bacterial components across the blood-brain barrier, initiating the physiologic changes involved in Alzheimer disease. In this review, we summarize recent data that support the relationship between vesicles secreted by periodontal pathogens to Alzheimer disease pathology.

Lactiplantibacillus argentoratensis AGMB00912 protects weaning mice from ETEC infection and enhances gut health.

Maintaining a healthy intestinal environment, optimal epithelial barrier integrity, and balanced gut microbiota composition are essential for the growth performance of weaning pigs. We identified Lactiplantibacillus argentoratensis AGMB00912 (LA) in healthy porcine feces as having antimicrobial activity against pathogens and enhanced short-chain fatty acid (SCFA) production. Herein, we assess the protective role of LA using a weaning mouse model with enterotoxigenic Escherichia coli (ETEC) infection. LA treatment improves feed intake and weight gain and alleviates colon shortening. Furthermore, LA inhibits intestinal damage, increases the small intestine villus height compared with the ETEC group, and enhances SCFA production. Using the Kyoto Encyclopedia of Genes and Genomes and other bioinformatic tools, including InterProScan and COGNIZER, we validated the presence of SCFA-producing pathways of LA and Lactiplantibacillus after whole genome sequencing. LA mitigates ETEC-induced shifts in the gut microbiota, decreasing the proportion of Escherichia and Enterococcus and increasing SCFA-producing bacteria, including Kineothrix, Lachnoclostridium, Roseuburia, Lacrimispora, Jutongia, and Blautia. Metabolic functional prediction analysis revealed enhanced functions linked to carbohydrate, amino acid, and vitamin biosynthesis, along with decreased functions associated with infectious bacterial diseases compared to the ETEC group. LA mitigates the adverse effects of ETEC infection in weaning mice, enhances growth performance and intestinal integrity, rebalances gut microbiota, and promotes beneficial metabolic functions. These findings validate the functionality of LA in a small animal model, supporting its potential application in improving the health and growth performance of weaning pigs.

Association between DEFB1 rs11362 and Caries Susceptibility in Permanent Dentition: A Cross Sectional Study.

Dental caries is a multifactorial chronic bacterial infectious disease. Variations in the predisposition of the general population to dental cavities suggest that genetic and immunological factors play significant roles in its pathogenesis. This study aims to explore the impact of the Beta-Defensin 1 (DEFB1) rs11362 polymorphism on caries susceptibility in permanent dentition among the Bai Kuyao and Zhuang ethnic groups in China. A sample of 754 adolescents aged 12-15 was randomly selected from primary and junior high schools in Nandan County, Guangxi, China. All adolescents underwent clinical examinations, and DNA samples were collected. The genotype of DEFB1 rs11362 was determined using single nucleotide polymorphism (SNP) typing. The concentration of human β Defensin 1 (hBD-1) protein in saliva was measured using a double-antibody sandwich enzyme-linked immunosorbent assay (ELISA). The distribution of the DEFB1 rs11362 T allele was lower in the Bai Kuyao group compared to the Zhuang group. The disparity in the rs11362 genotype was statistically significant in the superficial dentin caries subgroup of the Bai Kuyao population (p = 0.017). Following adjustment for all potential confounding variables, the analysis revealed a heightened risk of superficial dental caries among CT genotype carriers in the Bai Kuyao population under a co-dominant model (odds ratios (OR) = 2.70; 95% confidence intervals (CI) [1.35-5.44]; p = 0.005), and an increased risk among CC genotype carriers in the Bai Kuyao population under a dominant model (OR = 2.35; 95% CI [1.18-4.67]; p = 0.015). A significant difference (p < 0.05) was noted in the distribution of rs11362 genotypes and salivary hBD-1 levels among the Bai Kuyao group. Salivary hBD-1 levels were notably higher in the CC genotype group (4.12 ± 2.07 ng/mL) compared to both the CT (2.77 ± 1.62 ng/mL) and TT genotype groups (2.32 ± 0.98 ng/mL). The DEFB1 rs11362 polymorphism showed an association with caries susceptibility in permanent teeth and influenced hBD-1 protein expression in saliva. Consequently, the DEFB1 polymorphism likely represents a concealed risk factor for caries.

Integration and validation of host transcript signatures, including a novel 3-transcript tuberculosis signature, to enable one-step multiclass diagnosis of childhood febrile disease

BackgroundWhole blood host transcript signatures show great potential for diagnosis of infectious and inflammatory illness, with most published signatures performing binary classification tasks. Barriers to clinical implementation include validation studies, and development of strategies that enable simultaneous, multiclass diagnosis of febrile illness based on gene expression.MethodsWe validated five distinct diagnostic signatures for paediatric infectious diseases in parallel using a single NanoString nCounter® experiment. We included a novel 3-transcript signature for childhood tuberculosis, and four published signatures which differentiate bacterial infection, viral infection, or Kawasaki disease from other febrile illnesses. Signature performance was assessed using receiver operating characteristic curve statistics. We also explored conceptual frameworks for multiclass diagnostic signatures, including additional transcripts found to be significantly differentially expressed in previous studies. Relaxed, regularised logistic regression models were used to derive two novel multiclass signatures: a mixed One-vs-All model (MOVA), running multiple binomial models in parallel, and a full-multiclass model. In-sample performance of these models was compared using radar-plots and confusion matrix statistics.ResultsSamples from 91 children were included in the study: 23 bacterial infections (DB), 20 viral infections (DV), 14 Kawasaki disease (KD), 18 tuberculosis disease (TB), and 16 healthy controls. The five signatures tested demonstrated cross-platform performance similar to their primary discovery-validation cohorts. The signatures could differentiate: KD from other diseases with area under ROC curve (AUC) of 0.897 [95% confidence interval: 0.822–0.972]; DB from DV with AUC of 0.825 [0.691–0.959] (signature-1) and 0.867 [0.753–0.982] (signature-2); TB from other diseases with AUC of 0.882 [0.787–0.977] (novel signature); TB from healthy children with AUC of 0.910 [0.808–1.000]. Application of signatures outside of their designed context reduced performance. In-sample error rates for the multiclass models were 13.3% for the MOVA model and 0.0% for the full-multiclass model. The MOVA model misclassified DB cases most frequently (18.7%) and TB cases least (2.7%).ConclusionsOur study demonstrates the feasibility of NanoString technology for cross-platform validation of multiple transcriptomic signatures in parallel. This external cohort validated performance of all five signatures, including a novel sparse TB signature. Two exploratory multi-class models showed high potential accuracy across four distinct diagnostic groups.

Antimicrobial Activity of Senna didymobotrya and Thunbergia alata Plant Extracts Against Selected Bacterial Clinical Isolates from Kericho Referral Hospital in Kenya

Bacterial infections are distributed worldwide and cause deadly infectious bacterial diseases such as skin, soft tissue and respiratory tract infections, meningitis, and tuberculosis. Bacterial infections are very common and can be easily acquired since bacteria are ubiquitous. It has challenged modern healthcare providers; conventional drugs are costly and have side effects. Therefore, alternative remedies that are easily available, affordable, and effective are needed. This study was carried out to determine the antimicrobial activity of Senna didymobotrya and Thunbergia alata crude plant extracts against Staphylococcus aureus, Streptococcus pyogenes and pseudomonas aeruginosa common in Kericho County. Plant leaves of the two plants were sourced from two sites (Bomet and Kabianga), dried, milled into powder and solvent extracted using hexane, dichloromethane: methanol ratio (1:1) and methanol. Phytochemicals present in each plant extract were evaluated using standard laboratory procedures. Antimicrobial sensitivity testing, Minimum Inhibitory Concentrations (MICs) and Minimum Bactericidal Concentration (MBC) were determined. Discs impregnated with standard antibacterial drugs were used as positive control. Leaves of T. alata and Senna didymobotrya collected from Bomet contained 7.41% and 10.4% while those from Kabianga contained 8.07% and 17.71% of extracts respectively, suggesting that site conditions do not influence the percentage of extracts. Leave extracts of S. didymobotrya and T. alata were found to be rich in alkaloids, flavonoids, terpenoids, glycosides and tannins irrespective of plant collection site, solvent of extraction. S. didymobotrya and T. alata plant extracts significantly inhibited growth of the exposed microbes in the following order: S. aureus, ≥S. pyogenes and≥ P. aeruginosa bacteria in comparison with commercial antibiotics (penicillin, chloromphenical, and erythromycin). The MIC values of the isolates ranged from 20×10-3 mg/ml to 4.8 ×10-3 mg/ml. However, bacterial inhibition by plant extracts showed re-growth of S. pyogenes after 36 hours, suggesting bacteriostatic nature. These results suggest that S. didymobotrya and T. alata leaves contain significant amounts of alkaloids, flavonoids, terpenoids, glycosides and tannins hence can be used as traditional medicine to manage S. aureus, S. pyogenes and P. aeruginosa bacteria found on human skin

CuO/ZnO heterojunction nanofilm for effective photocatalytic disinfection

Pathogenic bacteria can spread rapidly from contaminated surfaces to human skin once humans touch such surfaces, resulting in contact infection and subsequent bacterial infectious diseases. In addition to the bacterial drug resistance induced by overuse of antibiotics, the commonly used antibiotic bacteria-killing strategy is unsuitable for surface sterilization of facilities. Herein, a heterojunction CuO/ZnO nanofilm was constructed on glass plates by calcination and atomic layer deposition. This film exhibited excellent photocatalytic antibacterial activity under visible light. The heterostructure between CuO and ZnO at the interface accelerated the separation of photogenerated electrons and holes, resulting in increased yield of reactive oxygen species, which effectively kill bacteria. After 5 min of simulated sunlight irradiation, the antibacterial efficiencies of CuO/ZnO against Staphylococcus aureus (S. aureus) and Escherichia coli (E. coli) were 99.68 ± 0.31 % and 96.49 ± 0.78 %, respectively. The photocatalytic antimicrobial nanofilm synthesized in this study can potentially be used for rapid and safe disinfection of contact surfaces in public facilities.

Bimetallic loaded ZIF-8 with peroxidase-like and photothermal activities for sensitive detection and efficient elimination of Listeria monocytogenes

Listeria monocytogenes is one of the main causes of bacterial infectious diseases, posing a grave threat to food safety and global public health. Therefore, sensitive and accurate detection and efficient elimination of L. monocytogenes to prevent secondary pollution is of great significance and necessary. Herein, a nanocomposite ZIF-8@Au@Pt NPs was synthesized with excellent peroxidase-like (POD) activity, SERS property and photothermal conversion property. ZIF-8@Au@Pt NPs was further cloaked with a specific aptamer (Apt2), thus presenting precise recognition to L. monocytogenes. Magnetic beads with good separation and enrichment effect were modified with another specific aptamer (Apt1), a sandwich complex was then obtained based on the high affinity of aptamers to L. monocytogenes. The supernatant containing unreacted ZIF-8@Au@Pt NPs were capable of oxidizing colorless 3,3′,5,5′-tetramethylbenzidine (TMB) into blue oxTMB in the presence of H2O2, thus enabling colorimetric testing. Meanwhile, the generated oxTMB exhibited a distinct SERS fingerprint, realizing accurate detection of L. monocytogenes through dual-mode (colorimetric and SERS), with respective detection limits of 7 CFU/mL and 5 CFU/mL. Moreover, ZIF-8@Au@Pt NPs demonstrated exceptional photothermal conversion ability (η = 71.72 %) under a near-infrared irradiation. Approaching 100 % bactericidal effect was obtained within 2 min on the precipitates by combining its function of producing reactive oxygen species (ROS) and the near-infrared photothermal property, effectively avoiding secondary pollution. The present study presented a novel approach for realizing sensitive and accurate detection and subsequent eradication of L. monocytogenes.

Near-Infrared Light-Mediated Antibacterial Photodynamic Therapy Based on Erythrosine-Functionalized Mesoporous Silica-Coated Upconversion Nanoplatform.

Infectious diseases caused by bacteria pose a serious threat to public health, and more worryingly, the unregulated application of antibiotics accelerates the emergence of bacterial resistance, presenting a major challenge to the effective treatment of infectious diseases caused by bacteria. Therefore, there is an urgent necessity to develop efficient and safe antimicrobial systems. Photodynamic therapy (PDT) is an attractive therapeutic approach that does not induce bacterial resistance. However, the clinical application of PDT has been limited by several factors, including the lower tissue penetration depth of photoactivation under visible light irradiation and the uncertain biosafety of photosensitizers (PS). This work presents an near infrared (NIR)-triggered core-shell upconversion nanoparticle-based PDT system composed of mesoporous silica-coated lanthanide-doped upconversion nanoparticles loaded with the photosensitizer erythrosine (UCSE). Upon NIR-triggering, erythrosine generates highly efficient reactive oxygen species that disrupt the cell membranes of Staphylococcus aureus and Escherichia coli, exhibiting a potent photodynamic antimicrobial effect. It is worth noting that the UCSE also exhibits excellent biosafety. In conclusion, we present an efficient NIR-triggered nanoantimicrobial system with excellent antimicrobial capacity and biosafety, which is a new therapeutic strategy for the control of bacterial infectious diseases.

Antimicrobial Resistance in Equines: A Growing Threat to Horse Health and Beyond-A Comprehensive Review.

The equine industry holds substantial economic importance not only in the USA but worldwide. The occurrence of various infectious bacterial diseases in horses can lead to severe health issues, economic losses, and restrictions on horse movement and trade. Effective management and control of these diseases are therefore crucial for the growth and sustainability of the equine industry. While antibiotics constitute the primary treatment strategy for any bacterial infections in horses, developing resistance to clinically important antibiotics poses significant challenges to equine health and welfare. The adverse effects of antimicrobial overuse and the escalating threat of resistance underscore the critical importance of antimicrobial stewardship within the equine industry. There is limited information on the epidemiology of antimicrobial-resistant bacterial infections in horses. In this comprehensive review, we focus on the history and types of antimicrobials used in horses and provide recommendations for combating drug-resistant bacterial infections in horses. This review also highlights the epidemiology of antimicrobial resistance (AMR) in horses, emphasizing the public health significance and transmission dynamics between horses and other animals within a One Health framework. By fostering responsible practices and innovative control measures, we can better help the equine industry combat the pressing threat of AMR and thus safeguard equine as well as public health.

Literature Review: Potential of Chinese Ketepeng Leaves (Cassia alata L.) as an Antibacterial Agent

Infectious diseases are diseases caused by bacteria. Several bacterial infectious diseases include bacteria that cause skin infections such as Staphylococcus aureus, Staphylococcus epidermidis, Propionibacterium acnes and Streptococcus pyogene, nosocomial pneumonia infections of the urinary tract by Pseudomonas aeruginosa and Klebsiella pneumoniae that cause Healthcare-Acquired Infections (HAIs). The drugs usually used to treat bacterial infections are antibiotics. Along with the increase in cases of infection, there is also an increase in the use of antibiotics. Widespread or irrational use of antibiotics can cause resistance, so alternatives are needed to overcome them. One plant that has potential as an antibacterial agent is the leaves of Chinese Ketepeng (Cassia alata L.). Chinese ketepeng leaves contain phytochemical compounds, namely flavonoids, saponins, tannins, alkaloids and phenols. Therefore, this literature review aims to determine the potential of Chinese Ketepeng (Cassia alata L.) leaf extract as an antibacterial agent. The method used is the Systematic Literature Review method by collecting data through databases such as Publish or Perish, PubMed, and Google Scholar. The search method uses the keywords "Chinese Ketepeng Plant", "Skin infection", "Antibacterial", "Disc diffusion", "Well diffusion", "Staphylococcus aureus", "Staphylococcus epidermidis", "Klebsiella pneumonia", "Shigella dysentriae", ”Propionibacterium acnes”, “Streptococcus sobrinus”, and “Pseudomonas aerugenosa”. The results of this review article show that ke tepeng china leaf extract is proven to have potential as an antibacterial agent which is characterized by the presence of an inhibition zone formed. The phytochemical content in Chinese ketepeng leaves such as flavonoids, saponins, tannins, alkaloids and phenols are thought to be antimicrobial. The difference in the diameter of the inhibition zone formed is influenced by the concentration of the extract, the type of solvent and the type of test microorganisms used. The types of solvents used are ethanol and methanol which are extracted by sonication and maceration.

EVALUATION OF WOUND HEALING IN POST-SURGICAL PATIENTS CAESAR THOSE USING ANTIBIOTIC DRUGS AT TANJUNG PURA HOSPITAL

Introduction The World Health Organization (WHO) estimates that 5-15% of births globally are surgical cesarean section. Indonesian Health 2017 shows that 17.02% of deliveries in Indonesia are cesarean sections. Surgical wound infections are infections from wounds obtained after surgery. This infection can occur 30-90 days after surgery. Appropriate use of prophylactic antibiotics intraoperatively can reduce Surgical wound infections. Antibiotics are the most widely used class of drugs related to bacterial infectious diseases. Types of research used is prospective survey research with an approach of studying and testing hypotheses related to ongoing experience. Sample studies were 20 respondents. This research uses quantitative descriptive data analysis with a prospective research design. Research results At the Pharmacy Installation at the Tanjung Pura Regional General Hospital, surgical wounds began to close/dry as much as 70% (14 patients) for compliance with the use of antibiotics according to the right indication, right dose, right patient, right drug. Conclusion of this research is that administering antibiotics affects wound healing in patients and can ensure accuracy in suitability. It is recommended that the hospital review the cleanliness of the surgical area in order to improve the quality of the hospital.

Adjusting the microbial ecosystem via a natural “spear and shield” implant coating: Engineering bacterial extracellular vesicles for infection treatment

Bacterial infectious diseases caused by microecological imbalance pose serious threats to human health, while conventional bacteriostatic strategies often suffer from limitations including imprecision and the emergence of antibiotic-resistant bacteria. In this study, bacterial extracellular vesicles (EVs), derived specifically from S. aureus, are applied to construct a stable implant coating mediated by poly (tannic acid) (pTA). The resultant EVs coating, functioning akin to a “spear and shield”, possesses the ability to autonomously discriminate between non-parental bacteria (N-bacteria) and parental bacteria (P-bacteria), bestowing implants with accurate and selective adjusting capacities in vitro and in vivo. Within this construct, the EVs coating of gram-positive bacteria alters bacterial metabolism and membrane transport, affecting gene mismatch repair. For N-bacteria, the EVs coating acts like a sharp spear, effectively combating their growth. Conversely, it functions as a protective shield, precisely fostering the growth of P-bacteria. The TA-mediated EVs coating provides a research basis for advancing research in microecological control of infectious diseases and the treatment of other diseases associated with microecological imbalances.